BlackRock Fund Advisors’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.47M | Buy |
217
+29
| +15% | +$331K | ﹤0.01% | 3120 |
|
|
2016
Q3 | $2.62M | Buy |
188
+11
| +6% | +$153K | ﹤0.01% | 3096 |
|
|
2016
Q2 | $2.69M | Buy |
177
+7
| +4% | +$107K | ﹤0.01% | 3114 |
|
|
2016
Q1 | $2.12M | Buy |
170
+29
| +21% | +$361K | ﹤0.01% | 3068 |
|
|
2015
Q4 | $2.74M | Buy |
141
+4
| +3% | +$77.8K | ﹤0.01% | 3070 |
|
|
2015
Q3 | $1.84M | Sell |
137
-1
| -0.7% | -$13.5K | ﹤0.01% | 3132 |
|
|
2015
Q2 | $2.38M | Buy |
138
+125
| +962% | +$2.15M | ﹤0.01% | 3150 |
|
|
2015
Q1 | $236K | Buy |
13
+1
| +8% | +$18.2K | ﹤0.01% | 3439 |
|
|
2014
Q4 | $148K | Buy |
12
+1
| +9% | +$12.3K | ﹤0.01% | 3550 |
|
|
2014
Q3 | $164K | Sell |
11
-1
| -8% | -$14.9K | ﹤0.01% | 3534 |
|
|
2014
Q2 | $210K | Buy |
+12
| New | +$210K | ﹤0.01% | 3471 |
|